Literature DB >> 11711167

WCST performance and schizotypal features in the first-degree relatives of patients with schizophrenia.

A Laurent1, D Duly, P Murry, N Foussard, S Boccara, F Mingat, J Dalery, T d'Amato.   

Abstract

Since the findings concerning the Wisconsin Card Sorting Test (WCST) performance of healthy first-degree relatives of patients with schizophrenia are equivocal, it still remains unclear whether the WCST may serve as a neuropsychological indicator of vulnerability to schizophrenia. The aim of this study was to evaluate whether the first-degree relatives' schizotypal features could account for these discrepancies. The subjects were 24 schizophrenic probands, 49 of their first-degree relatives and 41 normal controls. The computerized version of the WCST was used and schizotypy features were assessed using four of Chapman's scales. The patient group performed worse on the WCST and had higher scores of schizotypy than the control group. The relatives group did not significantly differ from the control, neither on the WCST performance nor on the scores of schizotypy. However, the subgroup of relatives and the subgroup of patients with high scores on the negative dimension of schizotypy showed a worse performance on the WCST than the subgroups with low scores. There were no differences on the WCST performance between the subgroups with high vs. low scores on the positive dimension of schizotypy. Thus, discrepancies across studies could be explained by a confounding factor represented by the negative dimension of schizotypy.

Entities:  

Mesh:

Year:  2001        PMID: 11711167     DOI: 10.1016/s0165-1781(01)00306-7

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  7 in total

Review 1.  Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyrinths.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

Review 2.  Endophenotypes in schizophrenia: a selective review.

Authors:  Allyssa J Allen; Mélina E Griss; Bradley S Folley; Keith A Hawkins; Godfrey D Pearlson
Journal:  Schizophr Res       Date:  2009-02-15       Impact factor: 4.939

3.  Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia.

Authors:  Christoph U Correll; Christopher W Smith; Andrea M Auther; Danielle McLaughlin; Manoj Shah; Carmel Foley; Ruth Olsen; Todd Lencz; John M Kane; Barbara A Cornblatt
Journal:  J Child Adolesc Psychopharmacol       Date:  2008-10       Impact factor: 2.576

4.  Nonverbal delayed recognition in the relatives of schizophrenia patients with or without schizophrenia spectrum.

Authors:  Olalla Robles; Teresa Blaxton; Helene Adami; Celso Arango; Gunvant Thaker; James Gold
Journal:  Biol Psychiatry       Date:  2007-10-03       Impact factor: 13.382

5.  POSITIVE AND NEGATIVE SUBCLINICAL SYMPTOMS AND MCCB PERFORMANCE IN NON-PSYCHIATRIC CONTROLS.

Authors:  Cole Korponay; George C Nitzburg; Anil K Malhotra; Pamela DeRosse
Journal:  Schizophr Res Cogn       Date:  2014-12-01

6.  Cognitive Functioning and Schizotypy: A Four-Years Study.

Authors:  Penny Karamaouna; Chrysoula Zouraraki; Stella G Giakoumaki
Journal:  Front Psychiatry       Date:  2021-01-08       Impact factor: 4.157

7.  Superior memory performance in healthy individuals with subclinical psychotic symptoms but without genetic load for schizophrenia.

Authors:  G Gagnon; S Kumar; J-R Maltais; A N Voineskos; B H Mulsant; T K Rajji
Journal:  Schizophr Res Cogn       Date:  2018-08-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.